We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Comparison between Single-Dose Esomeprazole- and Pantoprazole-Based Triple Therapy on the Effectiveness for Helicobacter pylori Eradication in Taiwanese Population.
- Authors
Hsiang-Yao Shih; Wang, Sophie S. W.; Chao-Hung Kuo; Fu-Chen Kuo; Yi-Yu Chen; Meng-Chieh Wu; Bi-Chuang Weng; Yi-Chern Lee; Chi-Tan Hu; Deng-Chyang Wu; Yen-Hsu Chen
- Abstract
Background and Study Aims. To compare the effectiveness of two regimens, single-dose esomeprazole- and pantoprazole-based triple therapy, for Helicobacter pylori (H. pylori) eradication. Patients and Methods. A total of 453 patients were enrolled for H. pylori eradication. They were randomly assigned to either EAC group (Esomeprazole 40 mg once daily, Amoxicillin 1 g twice daily, Clarithromycin 500 mg twice daily for 7 days) or PAC group (Pantoprazole 40 mg twice daily, Amoxicillin 1 g twice daily, Clarithromycin 500 mg twice daily for 7 days). Follow-up endoscopy or urea breath test was scheduled 12-16 weeks after the eradication to evaluate the therapeutic response. Results. Higher eradication rate in EAC group than PAC group was shown by intention-to-treat analysis (EAC 72% versus PAC 55%, P < 0.05) and per-protocol analysis (EAC 91% versus PAC 72%, P < 0.05). The incidence of adverse effects (EAC 19% versus PAC 17%, P = 0.712) and the compliance (EAC 87% versus PAC 91%, P = 0.083) were comparable between these 2 groups. Conclusions. Single-dose esomeprazole-based triple therapy is effective for H. pylori eradication.
- Subjects
TAIWAN; ESOMEPRAZOLE; DRUG efficacy; HELICOBACTER pylori infections; PROTON pump inhibitors; CLARITHROMYCIN; COMPARATIVE studies
- Publication
Gastroenterology Research & Practice, 2012, p1
- ISSN
1687-6121
- Publication type
Article
- DOI
10.1155/2012/674324